Cinacalcet metabolite M4
Based on 1 Customer Validation
Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease.
For research use only. We do not sell to patients.
- CAS No.: 104774-87-0
- Formula: C10H12F3N
- Molecular Weight:203.20
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Chemical Information
-
CAS No. 104774-87-0
-
Appearance Liquid (Density: 1.154±0.06 g/cm3)
-
Molecular Weight 203.20
-
Formula C10H12F3N
-
Color Colorless to light yellow
-
SMILES
NCCCC1=CC=CC(C(F)(F)F)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
Purity & Documentation
-
Data Sheet (263 KB)
-
SDS (102 KB)
- English - EN (102 KB)
- Français - FR (102 KB)
- Deutsch - DE (102 KB)
- Norwegian - NO (102 KB)
- Español - ES (102 KB)
- Swedish - SV (102 KB)
- Italian - IT (102 KB)
- Korean - KR (102 KB)
- Portuguese - PT (102 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kumar GN, et al. Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animalmodels. Drug Metab Dispos. 2004 Dec;32(12):1491-500. [Content Brief]
[2]. Bushinsky DA, et al. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int. 2006 May;69(9):1586-92. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cinacalcet metabolite M4 Related Classifications
HY-135601 Related Classifications
Powered by Bioz